Wide Ranks

DWTX

Dogwood Therapeutics, Inc.

2.60

Top Statistics
Market Cap 3 M Forward PE -0.4082 Revenue Growth 0.00 %
Current Ratio 0.00 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash Total Cash Per Share Total Debt
Total Debt To Equity Current Ratio 0.00 Book Value Per Share 4.94
All Measures
Short Ratio 47.00 % Message Board Id finmb_204765942 Shares Short Prior Month 62447
City Alpharetta Uuid 3d366d48-5ace-35a0-9034-9b0c5d6ef04a Previous Close 2.67
First Trade Date Epoch Utc 1 B Book Value 4.94 Volume 43493
Price To Book 0.5261 Last Split Date 1 B Fifty Two Week Low 1.62
Shares Short Previous Month Date 1 B Target Median Price 11.50 Max Age 86400
Sand P52 Week Change 0.3133 Target Mean Price 13.83 Net Income To Common -5725025
Ask 2.70 Short Percent Of Float 0.0247 Implied Shares Outstanding 1 M
Last Fiscal Year End 1 B Trailing Peg Ratio None Average Daily Volume10 Day 120810
Average Volume10days 120810 Next Fiscal Year End 1 B Held Percent Insiders 0.2148
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 2.67 Target Low Price 5.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 3.88 Open 2.73 Dividend Yield 0.00 %
State GA Time Zone Short Name EST Trailing Eps -6.32
Day Low 2.58 Address1 44 Milton Avenue Shares Outstanding 1 M
Price Hint 4 Target High Price 25.00 Website https://www.dwtx.com
52 Week Change -0.8172 Average Volume 105736 Forward Eps -6.37
Recommendation Key none Compensation As Of Epoch Date 1 B Last Split Factor 1:25
Regular Market Day High 2.87 Is_sp_500 False Profit Margins 0.00 %
Fifty Two Week High 23.50 Day High 2.87 Shares Short 31850
Regular Market Open 2.73 Industry Key biotechnology Bid 2.49
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0239
Currency USD Time Zone Full Name America/New_York Market Cap 3 M
Is_nasdaq_100 False Zip 30009 Quote Type EQUITY
Industry Biotechnology Long Name Dogwood Therapeutics, Inc. Regular Market Day Low 2.58
Held Percent Institutions 0.0339 Current Price 2.60 Financial Currency USD
Current Ratio 0.00 Industry Disp Biotechnology Number Of Analyst Opinions 3
Country United States Float Shares 722172 Two Hundred Day Average 6.62
Forward PE -0.4082 Regular Market Volume 43493 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response.

The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.

It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID.

The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024.

The company was founded in 2012 and is headquartered in Alpharetta, Georgia.